Compare VERA & IPAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VERA | IPAR |
|---|---|---|
| Founded | 2016 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.9B |
| IPO Year | 2021 | 1995 |
| Metric | VERA | IPAR |
|---|---|---|
| Price | $42.43 | $115.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 5 |
| Target Price | $81.30 | ★ $116.60 |
| AVG Volume (30 Days) | ★ 2.1M | 314.0K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.54% |
| EPS Growth | N/A | ★ 2.34 |
| EPS | N/A | ★ 1.35 |
| Revenue | N/A | ★ $1,317,700,000.00 |
| Revenue This Year | N/A | $3.86 |
| Revenue Next Year | $472.48 | $7.89 |
| P/E Ratio | ★ N/A | $90.56 |
| Revenue Growth | N/A | ★ 21.26 |
| 52 Week Low | $19.07 | $77.21 |
| 52 Week High | $56.05 | $139.00 |
| Indicator | VERA | IPAR |
|---|---|---|
| Relative Strength Index (RSI) | 59.68 | 66.67 |
| Support Level | $40.87 | $89.11 |
| Resistance Level | $43.30 | N/A |
| Average True Range (ATR) | 2.62 | 3.98 |
| MACD | 0.37 | 1.52 |
| Stochastic Oscillator | 68.92 | 70.43 |
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Interparfums Inc operates in the fragrance business and produces and distributes a wide array of prestige fragrance and fragrance-related products. It sells its product under the brand which includes Boucheron, Coach, Jimmy Choo, Karl Lagerfeld, Kate Spade, Lacoste, Lanvin, Moncler, Montblanc, Rochas and Van Cleef & Arpels. The company operates in two operating segments namely European based operations, SA, and United States based operations. The group sells its products to department stores, perfumeries, specialty stores, and domestic and international wholesalers and distributors.